
Pharma Business - August 7, 2013
Moberg Pharma extends distribution agreement in China
Menarini Asia-Pacific, a member of the Menarini Group, has been granted the exclusive rights to market and sell Moberg Pharma’s Kerasal Nail on the Chinese market. Kerasal Nail is a non-prescription product for the treatment of discoloured and deformed nails resulting from fungal infection or psoriasis. Since the launch in 2011 it has been launched in […]